Navignostics aims to identify the ideal treatment to each cancer patient’s disease.
Navignostics has raised $7.6M in total funding. The most recent round was Seed. The last funding was announced in November 2022.
Navignostics's investors include Zürcher Kantonal Bank, Bruker, Think.Health, Ventura BioMed Investors, UZH Life Sciences Fund.
Navignostics is headquartered in Zürich, Switzerland.
Navignostics aims to identify the ideal treatment to each cancer patient’s disease.
Navignostics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Navignostics — Funding & Investors." VCBacked, November 9, 2022, https://www.vcbacked.co/company/navignostics. Accessed August 13, 2026.
VCBacked. (2022). Navignostics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/navignostics
{{cite web |title=Navignostics — Funding & Investors |url=https://www.vcbacked.co/company/navignostics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated